Form 10-Q INFINITY PHARMACEUTICALS For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Infinity Pharma (INFI) Posts Mixed Q2 Results
August 9, 2016 4:49 PM EDTInfinity Pharma (NASDAQ: INFI) reported Q2 EPS of $1.05, $1.94 better than the analyst estimate of ($0.89). Revenue for the quarter came in at $9.5 million versus the consensus estimate of $13.91 million.
For earnings history and earnings-related data on Infinity Pharma (INFI) click here.
... More